Table 3A.
SNP |
Distance Between SNPS (bp) |
Gene |
Chr. |
MAF** |
Data Set 1. All participants, N=399 |
Data Set 2. Excluding Individual who are BRCA1or 2 Positive, N=333 |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Additive | Dominant | Additive | Dominant | |||||||||||
N | OR | p | OR | p | N | OR | p | OR | p | |||||
rs2075685 | XRCC4 | 5 | 0.39 | 358 | 1.33 | 0.060 | 1.75 | 0.015 | 300 | 1.43 | 0.033 | 1.94 | 0.010 | |
rs10474081 | 18218 | XRCC4 | 5 | 0.41 | 347 | 1.32 | 0.088 | 1.77 | 0.020 | 290 | 1.25 | 0.215 | 1.75 | 0.036 |
rs1120476 | 31760 | XRCC4 | 5 | 0.37 | 321 | 1.46 | 0.025 | 2.04 | 0.004 | 274 | 1.41 | 0.059 | 2.09 | 0.006 |
rs6464268 | 7016 | XRCC2 | 7 | 0.16 | 358 | 1.20 | 0.340 | 1.30 | 0.268 | 298 | 1.20 | 0.375 | 1.30 | 0.309 |
rs1063054 | NBS1 | 8 | 0.28 | 320 | 1.47 | 0.038 | 1.51 | 0.082 | 273 | 1.45 | 0.066 | 1.53 | 0.100 | |
rs16888927 | RAD21/hHR21 | 8 | 0.31 | 339 | 0.64 | 0.014 | 0.51 | 0.004 | 289 | 0.62 | 0.014 | 0.48 | 0.004 | |
rs16888997 | 6948 | RAD21/hHR21 | 8 | 0.29 | 347 | 0.56 | 0.003 | 0.48 | 0.002 | 294 | 0.53 | 0.003 | 0.45 | 0.002 |
rs16889040 | 1215 | RAD21/hHR21 | 8 | 0.29 | 356 | 0.63 | 0.019 | 0.57 | 0.013 | 298 | 0.58 | 0.010 | 0.50 | 0.006 |
rs2619681 | RAD51/RAD51a | 15 | 0.18 | 339 | 0.71 | 0.132 | 0.62 | 0.051 | 289 | 0.74 | 0.221 | 0.66 | 0.126 | |
rs2909430 | TP53 | 17 | 0.11 | 301 | 1.71 | 0.034 | 2.01 | 0.011 | 257 | 1.58 | 0.085 | 1.86 | 0.035 | |
rs4986763 | BRIP1 | 17 | 0.40 | 330 | 0.64 | 0.014 | 0.56 | 0.013 | 280 | 0.57 | 0.002 | 0.46 | 0.003 | |
rs8112515 | ZNF350 | 19 | 0.21 | 318 | 0.63 | 0.042 | 0.62 | 0.060 | 271 | 0.75 | 0.252 | 0.72 | 0.219 | |
Table 3B. Association of specific SNPs with breast cancer, adjusting for BRCA1 and BRCA2 status. | ||||||||||||||
SNP |
Distance between SNPS (bp) |
Gene |
Chr. |
MAF** |
Data Set 3. Including only individuals with known BRCA1 and BRCA2 status (N=306). |
|||||||||
Additive | Dominant | |||||||||||||
N | OR | p | OR | p | ||||||||||
rs2075685 | XRCC4 | 5 | 0.39 | 266 | 1.13 | 0.499 | 1.34 | 0.291 | ||||||
rs10474081 | 18218 | XRCC4 | 5 | 0.41 | 255 | 1.16 | 0.480 | 1.26 | 0.443 | |||||
rs1120476 | 31760 | XRCC4 | 5 | 0.37 | 241 | 1.41 | 0.087 | 1.75 | 0.053 | |||||
rs6464268 | 7016 | XRCC2 | 7 | 0.16 | 260 | 1.66 | 0.048 | 2.23 | 0.010 | |||||
rs1063054 | NBS1 | 8 | 0.32 | 240 | 1.37 | 0.146 | 1.37 | 0.252 | ||||||
rs16888927 | RAD21/hHR21 | 8 | 0.31 | 247 | 0.62 | 0.027 | 0.45 | 0.005 | ||||||
rs16888997 | 6948 | RAD21/hHR21 | 8 | 0.29 | 255 | 0.53 | 0.007 | 0.43 | 0.003 | |||||
rs16889040 | 1215 | RAD21/hHR21 | 8 | 0.29 | 259 | 0.54 | 0.009 | 0.47 | 0.006 | |||||
rs2619681 | RAD51/RAD51a | 15 | 0.18 | 248 | 0.68 | 0.138 | 0.56 | 0.043 | ||||||
rs2909430 | TP53 | 17 | 0.11 | 224 | 1.42 | 0.213 | 1.71 | 0.086 | ||||||
rs4986763 | BRIP1 | 17 | 0.40 | 240 | 0.68 | 0.046 | 0.64 | 0.101 | ||||||
rs8112515 | ZNF350 | 19 | 0.21 | 238 | 0.62 | 0.067 | 0.61 | 0.100 |
Models adjusted for age, education, and Ashkenazi Jewish ancestry.
Minor allele frequency (MAF)calculated using the unaffected individuals
Models adjusted for age, education, Ashkenazi Jewish ancestry, and BRCA1 and BRCA2 status.
Minor allele frequency (MAF) calculated using the unaffected individuals